Nouscom

Clinical-stage immuno-oncology company developing novel virus-based immunotherapies and personalized cancer vaccines designed to generate potent and durable anti-tumor T cell responses.

Location
Basel, Switzerland & Rome, Italy
Founded
2015
Investors
1
Categories
biotech, oncology, immunotherapy, cancer-vaccines

Investors

NameLocationTypeStagesPortfolio
Angelini VenturesRome, Italycvc
seedseries-a+2
4